| Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system … JS Weinstein, CG Varallyay, E Dosa, S Gahramanov, B Hamilton, ... Journal of Cerebral Blood Flow & Metabolism 30 (1), 15-35, 2010 | 583 | 2010 |
| Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature C Kleinschnitz, P Kraft, A Dreykluft, I Hagedorn, K Göbel, MK Schuhmann, ... Blood, The Journal of the American Society of Hematology 121 (4), 679-691, 2013 | 369 | 2013 |
| Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? EA Neuwelt, BE Hamilton, CG Varallyay, WR Rooney, RD Edelman, ... Kidney international 75 (5), 465-474, 2009 | 317 | 2009 |
| Current and potential imaging applications of ferumoxytol for magnetic resonance imaging GB Toth, CG Varallyay, A Horvath, MR Bashir, PL Choyke, ... Kidney international 92 (1), 47-66, 2017 | 286 | 2017 |
| The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study EA Neuwelt, CG Várallyay, S Manninger, D Solymosi, M Haluska, ... Neurosurgery 60 (4), 601-612, 2007 | 210 | 2007 |
| Pseudoprogression of glioblastoma after chemo-and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol … S Gahramanov, LL Muldoon, CG Varallyay, X Li, DF Kraemer, R Fu, ... Radiology 266 (3), 842-852, 2013 | 190 | 2013 |
| Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using … S Gahramanov, AM Raslan, LL Muldoon, BE Hamilton, WD Rooney, ... International Journal of Radiation Oncology* Biology* Physics 79 (2), 514-523, 2011 | 170 | 2011 |
| Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI KL Nguyen, T Yoshida, N Kathuria-Prakash, IH Zaki, CG Varallyay, ... Radiology 293 (3), 554-564, 2019 | 118 | 2019 |
| High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle CG Varallyay, E Nesbit, R Fu, S Gahramanov, B Moloney, E Earl, ... Journal of Cerebral Blood Flow & Metabolism 33 (5), 780-786, 2013 | 116 | 2013 |
| Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question M Nasseri, S Gahramanov, JP Netto, R Fu, LL Muldoon, C Varallyay, ... Neuro-oncology 16 (8), 1146-1154, 2014 | 111 | 2014 |
| C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms N Heydenreich, MW Nolte, E Göb, F Langhauser, M Hofmeister, P Kraft, ... Stroke 43 (9), 2457-2467, 2012 | 94 | 2012 |
| Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model CG Varallyay, LL Muldoon, S Gahramanov, YJ Wu, JA Goodman, X Li, ... Journal of Cerebral Blood Flow & Metabolism 29 (4), 853-860, 2009 | 92 | 2009 |
| In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging YJ Wu, LL Muldoon, C Varallyay, S Markwardt, RE Jones, EA Neuwelt American Journal of Physiology-Cell Physiology 293 (5), C1698-C1708, 2007 | 71 | 2007 |
| Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible? C Matthies, S Brill, C Varallyay, L Solymosi, G Gelbrich, K Roosen, ... Journal of neurosurgery 120 (2), 546-558, 2014 | 67 | 2014 |
| Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination X Li, WD Rooney, CG Várallyay, S Gahramanov, LL Muldoon, ... Journal of Magnetic Resonance 206 (2), 190-199, 2010 | 60 | 2010 |
| Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models YJ Wu, LL Muldoon, DT Dickey, SJ Lewin, CG Varallyay, EA Neuwelt Neoplasia 11 (2), 187-195, 2009 | 58 | 2009 |
| Neurovascular unit: basic and clinical imaging with emphasis on advantages of ferumoxytol JP Netto, J Iliff, D Stanimirovic, KA Krohn, B Hamilton, C Varallyay, ... Neurosurgery 82 (6), 770-780, 2018 | 53 | 2018 |
| Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival S Gahramanov, C Varallyay, RM Tyson, C Lacy, R Fu, JP Netto, ... CNS oncology 3 (6), 389-400, 2014 | 52 | 2014 |
| What does the boxed warning tell us? Safe practice of using ferumoxytol as an MRI contrast agent CG Varallyay, GB Toth, R Fu, JP Netto, J Firkins, P Ambady, EA Neuwelt American Journal of Neuroradiology 38 (7), 1297-1302, 2017 | 47 | 2017 |
| Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma ND Doolittle, K Jahnke, R Belanger, DA Ryan, RW Nance Jr, CA Lacy, ... Leukemia & lymphoma 48 (9), 1712-1720, 2007 | 44 | 2007 |
